elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38250849-9A56CA88-F813-4933-AFEF-36D0A0686268
Q38250849-9A56CA88-F813-4933-AFEF-36D0A0686268
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38250849-9A56CA88-F813-4933-AFEF-36D0A0686268
Suvorexant for insomnia: a systematic review of the efficacy and safety profile for this newly approved hypnotic - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
P2860
Q38250849-9A56CA88-F813-4933-AFEF-36D0A0686268
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38250849-9A56CA88-F813-4933-AFEF-36D0A0686268
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d678a292597eeb8e625e1eb170d8485ff7ab2f8a
P2860
Quantifying risk: the role of absolute and relative measures in interpreting risk of adverse reactions from product labels of antipsychotic medications.